Corryn Biotechnologies develops a handheld device that fabricates a breathable, porous matrix of extremely fine polymer fibres directly onto the skin to deliver benefits for cosmetic aftercare and beauty applications. The company has built clean room manufacturing capabilities and advanced fabrication and characterisation laboratories at the Bay Technology Centre in Port Talbot. Corryn is finalising regulatory approvals to allow commercial use of its technology as a cosmetic, initially targeting the UK and US markets with further territory expansion planned from 2027. It is building its intellectual property position with two patents pending related to the technology and material combinations. The business is anchored in Wales but is developing a presence in the US where one co-founder is based. The recent £500,000 equity raise is intended to accelerate commercial traction, scale manufacturing, and expand the team, supporting planned job creation in Wales.

Total raised

$1M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2026